In tumor cells, PARP7 inhibition using PARP7‐selective small molecules[16, 28, 29, 30] restored cytoplasmic NA‐dependent type I IFN signaling and reduced cancer cell growth in a cell‐autonomous manner (Figure 1). Here, TIPARP is linked to cancer.